Investing Profile

Leon Chen

InvestorVC
Partner at The Column Group
thecolumngroup.com/team/Palo Alto, California
Photo of Leon Chen, Partner at The Column Group

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
1253 CONNECTIONS
University of California, Berkeley Network
675 CONNECTIONS
Stanford University Graduate School of Business Network
528 CONNECTIONS
Financial Services, Financial Technology, and Business Services Network
258 CONNECTIONS
Venrock Network
40 CONNECTIONS
cb
$100K - $5.0M
$1.5M
9
$600M
CompanyStageDateRound SizeTotal Raised
Tr1x
Series UnknownOct 2025$50M
Series AJan 2024$75M
$130M
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
Series AMay 2021$150M
$1B
Co-investors: Elena Viboch (General Catalyst), Adam Goulburn (6 Dimensions Capital), Larry Lasky (The Column Group), Josh Wolfe (Lux Research), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Remix Therapeutics
Series BMay 2022$70M
Series ADec 2020$65M
$210M
Co-investors: Kevin Bitterman (Polaris Partners), Peter Svennilson (The Column Group), Kristina Burow (ARCH Venture Partners), Michael Rome (Foresite Capital)
Pionyr Immunotherapeutics
Series BDec 2017$62M
Series AJan 2017$8M
$79M
Co-investors: Carol Gallagher (New Enterprise Associates (NEA)), Michael Powell (Omega Funds), Arjun Goyal (Vida Ventures, LLC), Jack Kenney (Estuary Capital Management, LP)
PhD Student Financial Services, Financial Technology, and Business ServicesPresent
Entrepreneur in Residence VenrockPresent
Founder KAI PharmaceuticalsPresent
Partner Skyline VenturesPresent
Venture Partner OrbiMedPresent
Partner The Column GroupPresent
University of California, Berkeley Bachelor of Arts Biochemistry
Stanford University School of Medicine PhD Pharmacology
Stanford University Ph.D Molecular Pharmacology
Stanford University Graduate School of Business MBA Business
Sign in with Google →
Sign in with Google →